Literature DB >> 31064883

Polycystin 2 regulates mitochondrial Ca2+ signaling, bioenergetics, and dynamics through mitofusin 2.

Ivana Y Kuo1, Allison L Brill2, Fernanda O Lemos3, Jason Y Jiang4,5, Jeffrey L Falcone4,5, Erica P Kimmerling6, Yiqiang Cai7, Ke Dong7, David L Kaplan6, Darren P Wallace8, Aldebaran M Hofer4,5, Barbara E Ehrlich1,2.   

Abstract

Mitochondria and the endoplasmic reticulum (ER) have an intimate functional relationship due to tethering proteins that bring their membranes in close (~30 nm) apposition. One function of this interorganellar junction is to increase the efficiency of Ca2+ transfer into mitochondria, thus stimulating mitochondrial respiration. Here, we showed that the ER cation-permeant channel polycystin 2 (PC2) functions to reduce mitochondria-ER contacts. In cell culture models, PC2 knockdown led to a 50% increase in mitofusin 2 (MFN2) expression, an outer mitochondrial membrane GTPase. Live-cell super-resolution and electron microscopy analyses revealed enhanced MFN2-dependent tethering between the ER and mitochondria in PC2 knockdown cells. PC2 knockdown also led to increased ER-mediated mitochondrial Ca2+ signaling, bioenergetic activation, and mitochondrial density. Mutation or deletion of the gene encoding for PC2 results in autosomal dominant polycystic kidney disease (ADPKD), a condition characterized by numerous fluid-filled cysts. In cell culture models and mice with kidney-specific PC2 knockout, knockdown of MFN2 rescued defective mitochondrial Ca2+ transfer and diminished cell proliferation in kidney cysts. Consistent with these results, cyst-lining epithelial cells from human ADPKD kidneys had a twofold increase in mitochondria and MFN2 expression. Our data suggest that PC2 normally serves to limit key mitochondrial proteins at the ER-mitochondrial interface and acts as a checkpoint for mitochondrial biogenesis and bioenergetics. Loss of this regulation may contribute to the increased oxidative metabolism and aberrant cell proliferation typical of kidney cysts in ADPKD.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31064883      PMCID: PMC6855602          DOI: 10.1126/scisignal.aat7397

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  86 in total

1.  Regulation of the type III InsP(3) receptor by InsP(3) and ATP.

Authors:  R E Hagar; B E Ehrlich
Journal:  Biophys J       Date:  2000-07       Impact factor: 4.033

2.  Decreased polycystin 2 expression alters calcium-contraction coupling and changes β-adrenergic signaling pathways.

Authors:  Ivana Y Kuo; Andrea T Kwaczala; Lily Nguyen; Kerry S Russell; Stuart G Campbell; Barbara E Ehrlich
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

Review 3.  Endoplasmic reticulum-mitochondria contacts: function of the junction.

Authors:  Ashley A Rowland; Gia K Voeltz
Journal:  Nat Rev Mol Cell Biol       Date:  2012-09-20       Impact factor: 94.444

4.  The mTOR pathway is activated in human autosomal-recessive polycystic kidney disease.

Authors:  Jan Ulrich Becker; Anabelle Opazo Saez; Klaus Zerres; Oliver Witzke; Peter Friedrich Hoyer; Kurt Werner Schmid; Andreas Kribben; Carsten Bergmann; Jens Nürnberger
Journal:  Kidney Blood Press Res       Date:  2010-05-12       Impact factor: 2.687

Review 5.  Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.

Authors:  Vicente E Torres; Alessandra Boletta; Arlene Chapman; Vincent Gattone; York Pei; Qi Qian; Darren P Wallace; Thomas Weimbs; Rudolf P Wüthrich
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

Review 6.  MAM: more than just a housekeeper.

Authors:  Teruo Hayashi; Rosario Rizzuto; Gyorgy Hajnoczky; Tsung-Ping Su
Journal:  Trends Cell Biol       Date:  2009-01-12       Impact factor: 20.808

7.  Mitofusin 2 tethers endoplasmic reticulum to mitochondria.

Authors:  Olga Martins de Brito; Luca Scorrano
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962

8.  Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells.

Authors:  Cibele S Pinto; Gail A Reif; Emily Nivens; Corey White; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2012-09-05

9.  Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity.

Authors:  Ana Paula Arruda; Benedicte M Pers; Güneş Parlakgül; Ekin Güney; Karen Inouye; Gökhan S Hotamisligil
Journal:  Nat Med       Date:  2014-11-24       Impact factor: 53.440

10.  Emerging evidence of a link between the polycystins and the mTOR pathways.

Authors:  Alessandra Boletta
Journal:  Pathogenetics       Date:  2009-10-28
View more
  34 in total

1.  Deletion of cardiac polycystin 2/PC2 results in increased SR calcium release and blunted adrenergic reserve.

Authors:  Elisabeth DiNello; Elisa Bovo; Paula Thuo; Thomas G Martin; Jonathan A Kirk; Aleksey V Zima; Quan Cao; Ivana Y Kuo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-09-18       Impact factor: 4.733

2.  Polycystin 2: A calcium channel, channel partner, and regulator of calcium homeostasis in ADPKD.

Authors:  Allison L Brill; Barbara E Ehrlich
Journal:  Cell Signal       Date:  2019-12-02       Impact factor: 4.315

3.  Type 3 Inositol 1,4,5-Trisphosphate Receptor Is Increased and Enhances Malignant Properties in Cholangiocarcinoma.

Authors:  Pimwipa Ueasilamongkol; Tanaporn Khamphaya; Mateus T Guerra; Michele A Rodrigues; Dawidson A Gomes; Yong Kong; Wei Wei; Dhanpat Jain; David C Trampert; Meenakshisundaram Ananthanarayanan; Jesus M Banales; Lewis R Roberts; Farshad Farshidfar; Michael H Nathanson; Jittima Weerachayaphorn
Journal:  Hepatology       Date:  2019-08-19       Impact factor: 17.425

4.  The Mitochondrial Ca2+ import complex is altered in ADPKD.

Authors:  Murali K Yanda; Vartika Tomar; Robert Cole; William B Guggino; Liudmila Cebotaru
Journal:  Cell Calcium       Date:  2021-11-19       Impact factor: 6.817

5.  Pkd1 Mutation Has No Apparent Effects on Peroxisome Structure or Lipid Metabolism.

Authors:  Takeshi Terabayashi; Luis F Menezes; Fang Zhou; Hongyi Cai; Peter J Walter; Hugo M Garraffo; Gregory G Germino
Journal:  Kidney360       Date:  2021-07-16

Review 6.  Type 3 inositol 1,4,5-trisphosphate receptor: A calcium channel for all seasons.

Authors:  Anjali Mangla; Mateus T Guerra; Michael H Nathanson
Journal:  Cell Calcium       Date:  2019-11-25       Impact factor: 6.817

Review 7.  Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential.

Authors:  Kristen L Nowak; Katharina Hopp
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-21       Impact factor: 8.237

Review 8.  The pathobiology of polycystic kidney disease from a metabolic viewpoint.

Authors:  Luis Fernando Menezes; Gregory G Germino
Journal:  Nat Rev Nephrol       Date:  2019-09-05       Impact factor: 28.314

Review 9.  Endoplasmic Reticulum Calcium Homeostasis in Kidney Disease: Pathogenesis and Therapeutic Targets.

Authors:  Sun-Ji Park; Chuang Li; Ying Maggie Chen
Journal:  Am J Pathol       Date:  2020-11-24       Impact factor: 4.307

10.  BOK controls apoptosis by Ca2+ transfer through ER-mitochondrial contact sites.

Authors:  Marcos A Carpio; Robert E Means; Allison L Brill; Alva Sainz; Barbara E Ehrlich; Samuel G Katz
Journal:  Cell Rep       Date:  2021-03-09       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.